Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Cancer, Papillary × trametinib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 4 Multiple Myeloma 4 Hematologic Neoplasms 4 Lymphoma 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Skin Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibromatosis 1 1 Neurocytoma 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Hairy Cell 1 Klatskin Tumor 1

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 AZD 6244 2 vandetanib 1 tremelimumab 1 tovorafenib 1 tanespimycin 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 copanlisib 1 cediranib 1 alectinib 1 Vorinostat 1 Vemurafenib 1 Thyroidectomy 1 Thyroid (USP) 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Ferrosoferric Oxide 1 Ethanol 1 Bortezomib 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡